How do we identify the patients most likely to benefit from a given treatment?
Created by Laura Heiser lmheiser We are using noninvasive profiling of tumor (circulating tumor DNA) and immune (cellular deconvolution from RNA-seq) parameters to predict response to immune checkpoint blockade. Test by Lauren
Drop files to upload
How do we identify the patients most likely to benefit from a given treatment? page is loading…